Cinven To Buy Phadia

Cinven has agreed to acquire Sweden-based in vitro testing company Phadia AB from PPM Capital and Triton Partners for Euro 1.285 billion. The deal is expected to close in January, with leverage being provided by The Royal Bank of Scotland, Bayerische Hypo and Vereinsbank AG and UBS.